The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS‐TFCP2 fusion transcript

1 mai 2020Pediatric Blood & Cancer

DOI : 10.1002/pbc.28185

Auteurs

Anne‐Cécile Brunac, Anne Laprie, Marie‐Pierre Castex, Camille Laurent, François Le Loarer, Marie Karanian, Sophie Le Guellec, Delphine Guillemot, Gaelle Pierron, Anne Gomez‐Brouchet